EUVIMEDEUVIMED entdecken
Open Access

Transcatheter aortic valve-in-valve implantation for failed surgical aortic bioprostheses using the Navitor platform: early outcomes in a consecutive single-center cohort

Robert Sobczyński, Jarosław Trębacz, Paweł Kleczyński, Bogusław Kapelak, Maciej Stąpór, Filip Dudkowski, Janusz Konstanty-Kalandyk iD, Jacek Legutko

Cardiology Journal · 2026

DOI: 10.5603/cj.111703 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cardiology Journal, 2026. Verfasst von Robert Sobczyński und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Surgery and Transplantation, St. John Paul II Hospital, Krakow, Poland. sobczynski@poczta.fm. Hauptthemen laut MEDLINE: Bioprosthesis, Heart Valve Prosthesis, Aortic Valve, Transcatheter Aortic Valve Replacement. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Transcatheter heart valve implantation into a failed surgical heart valve (THV-in-SHV) is an established reintervention strategy for degenerated aortic bioprostheses; however, early procedural outcomes, discharge hemodynamics, and standardized safety remain clinically relevant in routine practice. Material and methods. We retrospectively analyzed consecutive patients who underwent aortic THV-in-SHV with the Navitor platform between 2022 and 2025. The primary endpoint was the mean aortic gradient at discharge. Secondary endpoints included peak gradient, maximum transvalvular velocity (Vmax), paravalvular leak (PVL), Valve Academic Research Consortium-3 (VARC-3) early safety, and time from surgical aortic valve replacement (SAVR) to reintervention according to leaflet mounting.

Results

Thirty patients were included (age, 72.5 ± 9.2 years; 73.3% male). At discharge, the mean and peak aortic gradients were 16.8 ± 6.7 mmHg and 30.0 ± 11.7 mmHg, respectively. Paravalvular leak was absent, trace, or mild in 96.7%, with no severe PVL. Early safety according to VARC-3 was achieved in 86.7%. Mortality and stroke occurred in 3.3% each, and bleeding type ≥ 2 occurred in 6.7%. No acute kidney injury (AKI) stage 3, renal replacement therapy (RRT), major vascular complications, device-related intervention, or new permanent pacemaker implantation occurred. Smaller surgical valves were associated with higher residual gradients, whereas outside-mounted bioprostheses showed a shorter time to reintervention than inside-mounted designs.

Conclusions

Aortic THV-in-SHV with the Navitor platform was associated with acceptable discharge hemodynamics, low rates of clinically relevant PVL, and favorable early safety according to VARC-3. Residual gradients were driven primarily by surgical valve size despite the intra-annular design.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BioprosthesisHeart Valve ProsthesisAortic ValveTranscatheter Aortic Valve ReplacementProsthesis FailureAortic Valve StenosisAortic Valve InsufficiencyHumansMaleFemaleRetrospective StudiesAgedProsthesis DesignTime FactorsHemodynamicsTreatment OutcomeReoperationFollow-Up StudiesAged, 80 and over

Stichwörter der Autor:innen

Navitoraortic bioprosthesis degenerationhemodynamicssafetyvalve-in-valve

Autor:innen und Institutionen

  • Department of Cardiac Surgery and Transplantation, St. John Paul II Hospital, Krakow, Poland. sobczynski@poczta.fm.
  • Department of Interventional Cardiology, St. John Paul II Hospital, Krakow, Poland.
  • Department of Interventional Cardiology, Institute of Cardiology, Jagiellonian University Medical College, St. John Paul II Hospital, Krakow, Poland.
  • Department of Cardiac Surgery and Transplantation, St. John Paul II Hospital, Krakow, Poland.
  • Department of Cardiac Surgery and Transplantation, Jagiellonian University Medical College, Institute of Cardiology, St. John Paul II Hospital, Krakow, Poland.
  • Gabriel Narutowicz Municipal Specialist Hospital, Krakow, Poland.

ORCID-Profile: Janusz Konstanty-Kalandyk

Zitieren

APA

Sobczyński, R., Trębacz, J., Kleczyński, P., Kapelak, B., Stąpór, M., Dudkowski, F., Konstanty-Kalandyk, J., & Legutko, J. (2026). Transcatheter aortic valve-in-valve implantation for failed surgical aortic bioprostheses using the Navitor platform: early outcomes in a consecutive single-center cohort. Cardiology Journal. https://doi.org/10.5603/cj.111703

Vancouver

Sobczyński R, Trębacz J, Kleczyński P, Kapelak B, Stąpór M, Dudkowski F, et al. Transcatheter aortic valve-in-valve implantation for failed surgical aortic bioprostheses using the Navitor platform: early outcomes in a consecutive single-center cohort. Cardiology Journal. 2026. doi:10.5603/cj.111703

BibTeX
@article{Sobczyski2026,
  author = {Sobczyński, Robert and Trębacz, Jarosław and Kleczyński, Paweł and Kapelak, Bogusław and Stąpór, Maciej and Dudkowski, Filip and Konstanty-Kalandyk, Janusz and Legutko, Jacek},
  title = {Transcatheter aortic valve-in-valve implantation for failed surgical aortic bioprostheses using the Navitor platform: early outcomes in a consecutive single-center cohort},
  journal = {Cardiology Journal},
  year = {2026},
  doi = {10.5603/cj.111703}
}
Kostenlos starten →